Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Motoya

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Inflammatory Bowel Diseases|February 8, 2013
Association study of 71 European Crohn's disease susceptibility loci in a Japanese populationAtsushi Hirano, Keiko Yamazaki, Junji Umeno, et al.
Digestion|December 5, 2019
Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire SurveyMariko Hojo, Akihito Nagahara, Ki-Baik Hahm, et al.
Journal of Gastroenterology and Hepatology|November 19, 2016
Caudal type homeobox 2 expression induced by leukocytapheresis might be associated with mucosal healing in ulcerative colitisKiichiro Tsuchiya, Ryohei Hayashi, Keita Fukushima, et al.
Journal of Gastroenterology and Hepatology|July 15, 2022
Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trialToshihiro Kita, Shinya Ashizuka, Teruyuki Takeda, et al.
Digestion|November 10, 2021
A Questionnaire-Based Survey on the Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy in AsiaKoji Otani, Toshio Watanabe, Akira Higashimori, et al.
Intestinal Research|July 14, 2025
Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational studyTaku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Journal of Gastroenterology|November 3, 2020
Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trialToshihiro Kita, Sinya Ashizuka, Naoki Ohmiya, et al.
Cell Genomics|February 13, 2023
Decoding the diversity of killer immunoglobulin-like receptors by deep sequencing and a high-resolution imputation methodSaori Sakaue, Kazuyoshi Hosomichi, Jun Hirata, et al.
Journal of Gastroenterology|May 2, 2019
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)Tadakazu Hisamatsu, Shingo Kato, Reiko Kunisaki, et al.
Intestinal Research|June 4, 2025
The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective studyTaku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Inflammatory Bowel Diseases|February 8, 2013
Association study of 71 European Crohn's disease susceptibility loci in a Japanese populationAtsushi Hirano, Keiko Yamazaki, Junji Umeno, et al.
Digestion|December 5, 2019
Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire SurveyMariko Hojo, Akihito Nagahara, Ki-Baik Hahm, et al.
Journal of Gastroenterology and Hepatology|November 19, 2016
Caudal type homeobox 2 expression induced by leukocytapheresis might be associated with mucosal healing in ulcerative colitisKiichiro Tsuchiya, Ryohei Hayashi, Keita Fukushima, et al.
Journal of Gastroenterology and Hepatology|July 15, 2022
Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trialToshihiro Kita, Shinya Ashizuka, Teruyuki Takeda, et al.
Digestion|November 10, 2021
A Questionnaire-Based Survey on the Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy in AsiaKoji Otani, Toshio Watanabe, Akira Higashimori, et al.
Intestinal Research|July 14, 2025
Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational studyTaku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Journal of Gastroenterology|November 3, 2020
Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trialToshihiro Kita, Sinya Ashizuka, Naoki Ohmiya, et al.
Cell Genomics|February 13, 2023
Decoding the diversity of killer immunoglobulin-like receptors by deep sequencing and a high-resolution imputation methodSaori Sakaue, Kazuyoshi Hosomichi, Jun Hirata, et al.
Journal of Gastroenterology|May 2, 2019
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)Tadakazu Hisamatsu, Shingo Kato, Reiko Kunisaki, et al.
Intestinal Research|June 4, 2025
The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective studyTaku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Pageof 9